Default Category
-
Embrace (B): Opportunity Assessment
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M005-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part B of a four-part series, which also includes 9B13M004, 9B13M006 and 9B13M007.Starting at €5.74
-
Embrace (C): Competing with Incumbents
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M006-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part C of a four-part series, which also includes 9B13M004, 9B13M005 and 9B13M007.Starting at €5.74
-
Oral Insulin: Breakthrough Innovation at Biocon
Nita Sachan; Prasad Kaipa; Anand Nandkumar; Charles DhanarajCase IVEY-9B11M065-EEntrepreneurship, Service and Operations Management, StrategyThis case deals with the innovation challenges of a medium-sized firm (under $1 billion) in an emerging economy (India), particularly the challenges of product development and commercialization. The management has to decide how to proceed with a promising novel formula for oral insulin — promising both in terms of financial returns as well as social impact. The company has spent several years of research and development in getting the drug throug...Starting at €8.20
-
Shanghai Pharmaceuticals
Herzlinger, Regina E.; Kindred, NatalieCase HBS-313016-EStrategyShanghai Pharmaceuticals (SPH), a vertically integrated Chinese pharmaceutical conglomerate, was considering its strategic options in the context of a rapidly evolving industry, policy, and economic environment. The company-essentially a collection of subsidiaries operating under a unified management structure-was formed through the 2009 merger of several state-owned enterprises, part of a broad policy effort in China to streamline state assets, ...Starting at €8.20
-
Acibadem Healthcare Group
Herzlinger, Regina E.; Cekin, Esel; Kindred, Natalie; Yucaoglu, GamzeCase HBS-315120-EThis case focuses on Ac badem Healthcare Group's, Turkey's only premium nationwide hospital network, potential expansion strategies after it was acquired by International Healthcare Holdings Berhad (IHH) in 2011, the world's second-largest publicly listed health care group and a private hospital leader in Singapore and Malaysia. By providing perspectives on both Ac badem and IHH-Parkway-Pantai's operational models, growth aspirations, collabora...Starting at €8.20
-
The Transformation of Mudo
Mayo, Anthony J.; Cekin, Esel; Celik, CigdemCase HBS-416015-ELeadership and People ManagementAfter 16 years in management consulting, Bar Karakulluk u left to become the CEO of Mudo in 2012, one of the best-known names in Turkey's retail industry. She was tasked with leading Mudo's transition from a family business to a more institutionalized, corporate structure and ensuring a smooth handover of the company from the first to the second-generation owner. As CEO, she makes a series of difficult decisions to transform the company. She...Starting at €8.20
-
La transformación de Mundo
Mayo, Anthony J.; Cekin, Esel; Celik, CigdemCase HBS-418S13Leadership and People ManagementDespués de 16 años en consultoría de gestión, Bar Karakulluk u dejaron para convertirse en el CEO de Mudo en 2012, uno de los más conocidos nombres de la industria al por menor de Turquía. Ella fue la tarea de dirigir la transición del Mudo de una empresa familiar a una estructura más institucionalizada, corporativa y asegurar una transferencia suave de la compañía de la primera a la segunda generación de propietarios. Como CEO, se hace una serie...Starting at €8.20
-
Centre for Cellular and Molecular Biology: The Commercialization Challenge
Nita Sachan; Prasad Vemuri; Anand Nandkumar; Charles DhanarajCase IVEY-9B11M064-ECorporate Governance, StrategyThis case deals with the commercialization challenges that a premier research institute in an emerging economy faces despite conducting cutting-edge research. The case is set in 2009 in Hyderabad, India, soon after the appointment of CCMB’s new director, Dr. Mohan Rao. Rao has to decide how to proceed with incentivizing the scientists to find potential applications for their research when most scientists are merely interested in doing basic resea...Starting at €8.20
-
Novartis in India: Innovation versus Affordability
Anand Nandkumar; Charles Dhanaraj; Mridula AnandCase IVEY-9B12M111-EStrategyThis case presents complex managerial challenges that stem from the institutional context in emerging markets, particularly in relation to the intellectual property regime and its impact on business strategy. The case centres around a multinational pharmaceutical firm, Novartis International AG (Novartis), that is waiting on a major court decision regarding patent policy as it pertains to one of the firm’s products. The case takes students throug...Starting at €8.20
-
Embrace (D): Building the Business Model
Mridula Anand; Anand Nandkumar; Charles DhanarajCase IVEY-9B13M007-EEntrepreneurship, StrategyAWARD WINNING CASE - Indian Management Issues and Opportunities Award, 2013 European Foundation for Management Development (EFMD) Case Writing Competition. Part D of a four-part series, which also includes 9B13M004, 9B13M005 and 9B13M006.Starting at €5.74